1-15 of 55
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Project Oncology®Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Charles Turck, PharmD, BCPS, BCCCP
Martin Dietrich, MD, PhD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALLAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Deep Breaths: Updates from CHESTClinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Gerard A. Silvestri MD, MS, Master FCCP
Adam H. Fox, MD, MSc
Anurag Singh, MD, PhD
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Project Oncology®Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley
Hallie Blevins, PhD
Marlene Mimi Maeusli, PhD.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Project Oncology®Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Balazs Halmos, MD, MS
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Project Oncology®Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Balazs Halmos, MD, MS
- advertisement
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's RoundtableUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Ashley Baker, MSN, PMHNP
Heather Allen, PhD
Ran Li, PhD
SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Project Oncology®SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Diagnosing LCNEC of the Lung: Challenges and Strategies
Project Oncology®Diagnosing LCNEC of the Lung: Challenges and Strategies
Junaid Arshad, MD, MS
Personalizing Care for Large Cell Neuroendocrine Carcinoma
Project Oncology®Personalizing Care for Large Cell Neuroendocrine Carcinoma
Junaid Arshad, MD, MS
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Project Oncology®DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
GI InsightsDevelopments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
Peter Buch, MD, FACG, AGAF, FACP
William Grady, MD
- advertisement
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA NephropathyDiagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
Gates B. Colbert, MD
Agnes B. Fogo, MD
Expert Insights on HER2 Scoring Criteria for Breast Cancer
Project Oncology®Expert Insights on HER2 Scoring Criteria for Breast Cancer
Jacob Sands, MD
Kathleen Fenn, MD
Oudai Hassan, MD
What to Know About the No Surprises Act
Perspectives with the AMAWhat to Know About the No Surprises Act
Charles Turck, PharmD, BCPS, BCCCP
Emily Carroll, JD, MSW
